| Composition | Ranolazine 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 10×10 |
| Packing | Alu-Alu |
RANOZIN 500 ER contains Ranolazine 500 mg, a cardiovascular medication specifically formulated for the management of chronic angina. This extended-release tablet helps reduce the frequency and severity of angina attacks by improving blood flow to the heart, without significantly affecting heart rate or blood pressure.
RANOZIN 500 ER is suitable for patients who require moderate angina relief while maintaining daily activities and quality of life.
Each tablet contains:
Ranolazine 500 mg (Extended-Release) – Anti-anginal agent that improves myocardial oxygen supply and reduces angina symptoms.
(Excipients q.s., as per approved formulation.)
Extended-Release Tablet
Anti-Anginal / Cardiovascular Medication
RANOZIN 500 ER Tablets are indicated for:
Chronic stable angina pectoris
Patients requiring reduction in angina attack frequency
Adjunct therapy in combination with beta-blockers, calcium channel blockers, or nitrates
Ranolazine inhibits late sodium currents in cardiac cells, reducing intracellular calcium overload.
This action relaxes the heart muscle, improves myocardial blood flow, and decreases angina symptoms.
Unlike other anti-anginal agents, it does not significantly affect heart rate or blood pressure, allowing safe use in combination therapy.
Recommended Dose: As prescribed by the physician, usually once or twice daily
Route: Oral
Duration: Long-term therapy as advised by a healthcare provider
Note: Swallow the tablet whole; do not crush, split, or chew. Regular monitoring by a physician is recommended.
Reduces frequency and severity of angina attacks
Improves exercise tolerance
Can be combined safely with other anti-anginal medications
Extended-release formulation allows convenient once or twice daily dosing
Supports overall cardiovascular health
RANOZIN 500 ER is generally well tolerated. Possible side effects include:
Dizziness or headache
Constipation or nausea
Rarely, palpitations or QT interval prolongation
Fatigue
Consult a physician if side effects persist or worsen.
Avoid in patients with pre-existing QT prolongation, liver impairment, or certain arrhythmias
Not recommended during pregnancy or lactation unless prescribed
Inform your doctor about other medications to prevent drug interactions
Regular cardiac monitoring is advised for high-risk patients
Store below 25°C, in a dry place away from sunlight. Keep out of reach of children.
Brand Name: RANOZIN 500 ER
Composition: Ranolazine 500 mg (Extended-Release)
Dosage Form: Extended-Release Tablet
Therapeutic Class: Anti-Anginal / Cardiovascular Medication
Manufacturer: [Insert Company Name]
Packaging: [Example: 10×10 Tablets / Strip]
Provides effective relief from chronic angina
Improves exercise tolerance and daily activity
Convenient extended-release formulation for better adherence
Manufactured under strict GMP-certified quality standards
RANOZIN 500 ER (Ranolazine 500 mg Extended-Release Tablets) delivers effective management of chronic angina by reducing angina frequency and severity while maintaining stable heart rate and blood pressure. It supports daily activities and long-term cardiovascular wellness for patients with chronic angina.